Marco-Brualla, J.; Gonzalo, O.; Azaceta, G.; Izquierdo, I.; Palomera, L.; Villalba, M.; Marzo, I.; Anel, A.
The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL. Cells 2025, 14, 1343.
https://doi.org/10.3390/cells14171343
AMA Style
Marco-Brualla J, Gonzalo O, Azaceta G, Izquierdo I, Palomera L, Villalba M, Marzo I, Anel A.
The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL. Cells. 2025; 14(17):1343.
https://doi.org/10.3390/cells14171343
Chicago/Turabian Style
Marco-Brualla, JoaquÃn, Oscar Gonzalo, Gemma Azaceta, Isabel Izquierdo, Luis Palomera, MartÃn Villalba, Isabel Marzo, and Alberto Anel.
2025. "The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL" Cells 14, no. 17: 1343.
https://doi.org/10.3390/cells14171343
APA Style
Marco-Brualla, J., Gonzalo, O., Azaceta, G., Izquierdo, I., Palomera, L., Villalba, M., Marzo, I., & Anel, A.
(2025). The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL. Cells, 14(17), 1343.
https://doi.org/10.3390/cells14171343